Recent Drug Discovery Research for May 2025
Endometrial Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Women's Health, Oncology/Hematology, Obstetrics/Gynecology
| Vaginal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Asthma, Cancer Treatment, Drug Discovery, Women's Health, Oncology/Hematology, Obstetrics/Gynecology
| Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Diabetes, Drug Discovery
| Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Diabetes, Drug Discovery
| Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Global Castrate Resistant Prostate Cancer Therapeutics Market Insights, Forecast to 2028
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology, Men's Health
Regions: Global
| Type 2 Diabetes Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029
Topics: Diabetes, Drug Discovery, Clinical Trial
| Dry Eye Syndrome Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2018-2028
Topics: Over-the-Counter Drugs, Drug Discovery, Clinical Trial, Ophthalmology
| Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Hospitals & Clinics, Drug Discovery, Infectious Diseases
Regions: Global
| Tinea pedis (Athlete Foot) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Dermatology
Regions: Global
| Meningitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Research & Development, Drug Discovery, CNS/Neurology
Regions: Global
| Toxoplasmosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Infectious Diseases
Regions: Global
| Middle East Respiratory Syndrome (MERS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Infectious Diseases, Respiratory/Pulmonary
Regions: Middle East, Global
| Dengue Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Dengue, Drug Discovery
Regions: Global
| Influenza A Virus, H7N9 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Influenza, Drug Discovery
Regions: Global
| Poliomyelitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Infectious Diseases
Regions: Global
| Western Equine Encephalitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Livestock, Veterinary Health, Drug Discovery
| Familial Amyloid Neuropathies Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Pituitary ACTH Hypersecretion (Cushing Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Hyperphosphatemia In Chronic Kidney Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Graves' Ophthalmopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Graves' Disease, Drug Discovery, Ophthalmology
| Age Related Macular Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Ophthalmology
| Presbyopia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Ophthalmology
| Cervical Intraepithelial Neoplasia (CIN) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Women's Health, Obstetrics/Gynecology
| Female Sexual Dysfunction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Women's Health, Obstetrics/Gynecology
| Colon Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Kidney Cancer (Renal Cell Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology, Renal
| Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Cancer Treatment, Drug Discovery, Oncology/Hematology, Renal
| Serine/Threonine Protein Kinase A Raf (Proto Oncogene A Raf or Proto Oncogene Pks or ARAF or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| 2023 Global Antipsychotic Drugs Industry (2029 Outlook)
Topics: Prescription Drugs, Drug Discovery, CNS/Neurology
Regions: Global
| 2023 Global Breast Cancer Therapeutics Industry (2029 Outlook)
Topics: Cancer Treatment, Drug Discovery, Women's Health, Oncology/Hematology
Regions: Global
| Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Sodium and Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, CNS/Neurology
| Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Myelodysplastic Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Bladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
|
Prev | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
